What is Esmolol?
Esmolol is a short-acting beta-blocker used to control heart rate and blood pressure. It is administered intravenously, often in emergency situations or during surgery, to manage supraventricular tachycardias and other cardiac conditions [1].
What is Esmolol Brand Name?
Esmolol is marketed under the brand name Brevibloc [1].
How long does Esmolol take to work?
Brevibloc, the brand name for esmolol, acts rapidly. Its onset of action is typically within minutes of administration, and its effects can be quickly titrated or discontinued due to its very short half-life [1].
Can Esmolol be used during pregnancy?
The use of esmolol during pregnancy requires careful consideration. While it can cross the placenta, its administration is generally reserved for situations where the potential benefit justifies the potential risk to the fetus. The American College of Obstetricians and Gynecologists acknowledges the use of beta-blockers in managing certain maternal conditions, but specific guidance on esmolol in pregnancy should be sought from medical professionals [2].
How does Esmolol compare to other beta-blockers?
Esmolol's primary distinction from other beta-blockers is its ultra-short duration of action. This characteristic makes it particularly useful for rapid control of heart rate and blood pressure in acute settings, as its effects can be reversed quickly by stopping the infusion. Other beta-blockers have longer half-lives and are typically used for chronic management of conditions like hypertension and heart failure [1].
When does Brevibloc patent expire?
Information regarding the specific patent expiry dates for Brevibloc is often dynamic and subject to various patent protections and extensions. Resources like DrugPatentWatch.com track these details, which are crucial for understanding when generic versions may become available [3].